An alternative explanation for the conflicting results regarding EAAT2 levels and glutamate uptake may be that other transporters—for example, EAAT3—are responsible for the increased glutamate uptake in MS tissues. This evidence concerns the gene SLC1A1 and myeloid sarcoma.